Developing a new treatment for COVID-19
DEVELOPMENT OF A COMPOUND FOR THE TREATMENT OF COVID-19
This study is testing a new antiviral medication aimed at helping people with COVID-19, and it will involve patients to see how well the treatment works and how safe it is.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Aligos Therapeutics, INC. NIH-funded |
| Lab location | 1 site (South San Francisco, United States) |
| Project ID | NIH-10933185 on NIH RePORTER |
What this research studies
This research focuses on creating a new antiviral medication specifically designed to combat COVID-19. It involves a series of advanced development activities, including optimizing the chemical composition of the drug, ensuring it can be manufactured safely and effectively, and conducting thorough assessments of its safety and efficacy in clinical settings. Patients may be involved in trials to evaluate how well this new treatment works against the virus. The goal is to progress this therapeutic candidate through the necessary stages to make it available for public use.
Who could benefit from this research
Good fit: Ideal candidates for participation would include individuals diagnosed with COVID-19 who are seeking new treatment options.
Not a fit: Patients who are not currently infected with COVID-19 or those who have already recovered may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a new effective treatment option for COVID-19 patients.
How similar studies have performed: Previous research has shown promise in developing antiviral treatments for COVID-19, indicating that this approach has potential for success.
Where this research is happening
South San Francisco, United States
- Aligos Therapeutics, INC. — South San Francisco, United States (Active)
Researchers
- Principal investigator: Wang, Stanley — Aligos Therapeutics, INC.
- Study coordinator: Wang, Stanley
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.